↓ Skip to main content

Dove Medical Press

Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report

Overview of attention for article published in OncoTargets and therapy, September 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
32 Mendeley